Our Annual Review 2019

Download our 2019 Annual Review here.

Latest

New Research on the Importance of Exercise

This week, researchers at the Radboud University Medical Centre in Nijmegen (the Netherlands) published the results of a clinical trial evaluating an 'at home' high intensity exercise regime in people with Parkinson's, and they found that it had a positive effect.
From Prostates to Parkinson's

Chinese researchers in collaboration with scientists from the University of Iowa have today published new research suggesting that a drug, called Terazosin - which is used to treat enlarged prostates and high blood pressure - could be a useful drug to re-purpose for Parkinson's.
Kiltwalk: Glasgow

Don your tartan kilt and experience the city of Glasgow when you join the fun and lively 2020 Glasgow Kiltwalk in support of CPT!
Team UK YOPDFC bring home bronze from the Ray Kennedy Cup

On Saturday 31st August, a team of footballers who have each been diagnosed with Parkinson’s travelled to Copenhagen to represent the UK in the international Ray Kennedy Cup.

New Research on the Importance of Exercise

This week, researchers at the Radboud University Medical Centre in Nijmegen (the Netherlands) published the results of a clinical trial evaluating an 'at home' high intensity exercise regime in people with Parkinson's, and they found that it had a positive effect.
From Prostates to Parkinson's

Chinese researchers in collaboration with scientists from the University of Iowa have today published new research suggesting that a drug, called Terazosin - which is used to treat enlarged prostates and high blood pressure - could be a useful drug to re-purpose for Parkinson's.
Enterin Announce Clinical Trial Results

Recently announced results from a clinical trial provide interesting support for a major theory about Parkinson's, and hope for individuals suffering from one of the common non-motor issues, constipation.
Microglia - Why They Are Important in the Parkinsonian Brain

In this study, Prof. Brundin and his team demonstrate the importance of microglia (the immune cells in the brain) to the transfer of the Parkinson's-associated protein alpha synuclein in the brain. They suggested that pharmacological regulation of neuroinflammation could represent a future therapy for Parkinson's...
The Linked Clinical Trials Meeting 2019

The 2019 international Linked Clinical Trials meeting was held at the end of August in Grand Rapids, Michigan - this annual event is an important date in our calendar and heralds the process by which we are bringing much needed novel therapies for the Parkinson's into clinical trial as quickly as possible...
The BRAIN Tapping Test Goes Mobile

Researchers at UCL have recently published a study validating a mobile device test which could continually monitor individuals with Parkinson's...
Bayer Buys Blue Rock

Bayer pharmaceutical has bought BlueRock Therapeutics which could have some important implications for the Parkinson's community...
CPT Welcomes New Director of Fundraising & Marketing

The Cure Parkinson's Trust is delighted to announce Rick Lay in a new role as Director of Fundraising and Marketing.
Tracking and Monitoring Parkinson's Symptoms at Home

People with Parkinson’s could see their care transformed thanks to the development of a new service involving wearable technology...
Over Reacting to an Absence of PINK

Two genes when mutated, PINK1 and PARKIN, are associated with young onset Parkinson's. Exactly why they increase the risk of developing Parkinson's has long been a mystery, but now Canadian scientists have published research that might be able to explain this increased susceptibility...

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
The Grouse & Grape Luncheon

The Grouse and Grape Luncheon will return to Spencer House on the 8th October 2019 where over 300 guests will be welcomed to take part in this flourishing networking event, all in the aid of The Cure Parkinson's Trust.

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more